Your browser doesn't support javascript.
loading
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.
Feldman, Darren R; Ged, Yasser; Lee, Chung-Han; Knezevic, Andrea; Molina, Ana M; Chen, Ying-Bei; Chaim, Joshua; Coskey, Devyn T; Murray, Samuel; Tickoo, Satish K; Reuter, Victor E; Patil, Sujata; Xiao, Han; Aghalar, Jahan; Apollo, Arlyn J; Carlo, Maria I; Motzer, Robert J; Voss, Martin H.
Afiliação
  • Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ged Y; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Lee CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Knezevic A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Molina AM; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Chen YB; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chaim J; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Coskey DT; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Murray S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tickoo SK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Reuter VE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Patil S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Xiao H; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Aghalar J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Apollo AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey.
  • Carlo MI; Department of Medicine, Memorial Sloan Kettering Cancer Center, Commack, New York.
  • Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, Center at Rockville Center, Woodmere, New York.
  • Voss MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer ; 126(24): 5247-5255, 2020 12 15.
Article em En | MEDLINE | ID: mdl-32975815
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Everolimo / Bevacizumab / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Everolimo / Bevacizumab / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article